|
|
Line 7: |
Line 7: |
|
| |
|
|
| |
|
| ::* 2. '''Outpatient treatment'''
| |
| ::* 2.1 Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection:
| |
| :::* Preferred regimen:[[Macrolides]] ([[azithromycin]], [[clarithromycin]], {{or}} [[erythromycin]]) (strong recommendation)
| |
| :::* Alternative regimen: [[Doxycycline]]
| |
| :::* 2.2 Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A [[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] Option B [[beta-lactam]] {{and}} a [[macrolide]]
| |
| :::* 2.3 Preferred regimen in regions with a high rate of infection macrolide resistant S. pneumoniae: [[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] and [[beta-lactam]] {{and}} a [[macrolide]]
| |
|
| |
|
| | |
|
| |
|
| ::* 3. '''Inpatient non Intensive care unit treatment'''
| | |
| :::* Preferred regimen:[[fluoroquinolone]]
| |
| :::* Preferred regimen in level one evidence: [[beta-lactam]] {{and}} [[macrolide]](Preferred [[beta-lactam]] agents include [[cefotaxime]], [[ceftriaxone]], and [[ampicillin]]; [[ertapenem]] for selected patients
| |
| :::* Preferred regimen in level two evidence: [[beta-lactam]] ([[cefotaxime]], [[ceftriaxone]] {{or}} [[ampicillin-sulbactam]]) {{and}} either [[azithromycin]] {{or}} [[fluoroquinolone]]
| |
| :::* Preferred regimen in level three evidence: [[doxycycline]] as an alternative to [[macrolide]] {{or}} [[fluoroquinolone]] for [[penicillin allergic patients]]
| |
| :::* Preferred regimen in Penicillin allergic patients: [[Fluoroquinolone]] {{and}} [[aztreonam]]
| |
| :::* Preferred regimen for Community acquired methicillin resistant staphylococcus aureus infection: [[vancomycin]] {{or}} [[linezolid]]
| |
| | |
| | |
| | |
| ::* 3. '''Inpatient Intensive care unit treatment'''
| |
|
| |
|
| ==References== | | ==References== |
| {{reflist}} | | {{reflist}} |